Michael V. Seiden, MD, PhD
President/CEO
Fox Chase Cancer Center

Michael V. Seiden, M.D., Ph.D., comes to Fox Chase from Massachusetts General Hospital and Dana-Farber/Harvard Cancer Center, where he led the gynecologic cancer program and served as chief of the clinical research unit in Massachusetts General's division of cancer medicine. In addition, his responsibilities included serving as associate professor of medicine at Harvard Medical School and physician coordinator of the cancer stem-cell project at Dana-Farber/Harvard Cancer Center. His research focuses on clinical and translational studies in ovarian cancer. Translational studies are designed to expedite the application of laboratory discoveries to clinical therapies for patients and to use clinical insights to form testable questions in the laboratory to help advance our understanding of cancer biology.

As chairman of the clinical research committee for the Gynecologic Cancer Program at Dana-Farber/Harvard Cancer Center, Seiden led and fostered a multi-institutional, multi-specialist program with a full range of phase I and II trials, an ovarian tumor bank for translational research, a quality-of-life program and efforts to improve care in underserved populations.

Seiden serves on the editorial boards of the journals Clinical Cancer Research, the Journal of Clinical Oncology and The Oncologist and is an ad hoc reviewer for a number of others, including The New England Journal of Medicine and British Journal of Cancer. He is also active in many professional organizations and has served on various national and international committees and advisory boards.